STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹92 Cr | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr |
| Equity - Authorised | ₹218 Cr | ₹218 Cr | ₹188 Cr | ₹188 Cr | ₹188 Cr |
| Equity - Issued | ₹92 Cr | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr |
| Equity Paid Up | ₹92 Cr | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹0.56 Cr | ₹0.51 Cr | ₹3.09 Cr | ₹19 Cr | ₹2.45 Cr |
| Total Reserves | ₹3,015 Cr | ₹2,459 Cr | ₹2,031 Cr | ₹2,103 Cr | ₹2,267 Cr |
| Securities Premium | ₹1,510 Cr | ₹1,509 Cr | ₹1,823 Cr | ₹1,754 Cr | ₹1,732 Cr |
| Capital Reserves | ₹-121 Cr | ₹-115 Cr | ₹33 Cr | ₹36 Cr | ₹34 Cr |
| Profit & Loss Account Balance | ₹978 Cr | ₹459 Cr | ₹-284 Cr | ₹-200 Cr | ₹2.31 Cr |
| General Reserves | ₹404 Cr | ₹404 Cr | ₹404 Cr | ₹404 Cr | ₹404 Cr |
| Other Reserves | ₹243 Cr | ₹202 Cr | ₹55 Cr | ₹109 Cr | ₹95 Cr |
| Reserve excluding Revaluation Reserve | ₹3,015 Cr | ₹2,459 Cr | ₹2,031 Cr | ₹2,103 Cr | ₹2,267 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹3,108 Cr | ₹2,552 Cr | ₹2,126 Cr | ₹2,212 Cr | ₹2,359 Cr |
| Minority Interest | ₹42 Cr | ₹35 Cr | ₹-54 Cr | ₹-39 Cr | ₹24 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹536 Cr | ₹559 Cr | ₹618 Cr | ₹1,041 Cr | ₹745 Cr |
| Non Convertible Debentures | - | - | ₹123 Cr | ₹121 Cr | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹536 Cr | ₹559 Cr | ₹661 Cr | ₹1,042 Cr | ₹1,117 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹0.04 Cr | ₹0.10 Cr | ₹-165 Cr | ₹-122 Cr | ₹-372 Cr |
| Unsecured Loans | ₹16 Cr | ₹13 Cr | ₹53 Cr | ₹99 Cr | ₹91 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹16 Cr | ₹13 Cr | ₹57 Cr | ₹102 Cr | ₹94 Cr |
| Other Unsecured Loan | - | - | ₹-3.83 Cr | ₹-3.04 Cr | ₹-3.59 Cr |
| Deferred Tax Assets / Liabilities | ₹-163 Cr | ₹-150 Cr | ₹-227 Cr | ₹-220 Cr | ₹-179 Cr |
| Deferred Tax Assets | ₹284 Cr | ₹266 Cr | ₹270 Cr | ₹326 Cr | ₹295 Cr |
| Deferred Tax Liability | ₹121 Cr | ₹117 Cr | ₹43 Cr | ₹106 Cr | ₹116 Cr |
| Other Long Term Liabilities | ₹83 Cr | ₹66 Cr | ₹85 Cr | ₹218 Cr | ₹245 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹126 Cr | ₹114 Cr | ₹92 Cr | ₹73 Cr | ₹64 Cr |
| Total Non-Current Liabilities | ₹599 Cr | ₹602 Cr | ₹621 Cr | ₹1,210 Cr | ₹966 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹1,310 Cr | ₹1,032 Cr | ₹852 Cr | ₹982 Cr | ₹1,072 Cr |
| Sundry Creditors | ₹1,310 Cr | ₹1,032 Cr | ₹852 Cr | ₹982 Cr | ₹1,072 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹402 Cr | ₹307 Cr | ₹342 Cr | ₹528 Cr | ₹697 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹31 Cr | ₹30 Cr | ₹26 Cr | ₹32 Cr | ₹28 Cr |
| Interest Accrued But Not Due | ₹6.94 Cr | ₹7.48 Cr | ₹11 Cr | ₹16 Cr | ₹5.81 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | ₹50 Cr | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹364 Cr | ₹270 Cr | ₹255 Cr | ₹480 Cr | ₹663 Cr |
| Short Term Borrowings | ₹1,039 Cr | ₹1,136 Cr | ₹1,574 Cr | ₹1,331 Cr | ₹1,497 Cr |
| Secured ST Loans repayable on Demands | ₹886 Cr | ₹1,004 Cr | ₹1,468 Cr | ₹1,227 Cr | ₹1,364 Cr |
| Working Capital Loans- Sec | ₹795 Cr | ₹897 Cr | ₹1,247 Cr | ₹956 Cr | ₹1,013 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-642 Cr | ₹-765 Cr | ₹-1,142 Cr | ₹-851 Cr | ₹-881 Cr |
| Short Term Provisions | ₹145 Cr | ₹115 Cr | ₹112 Cr | ₹149 Cr | ₹146 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹48 Cr | ₹34 Cr | ₹40 Cr | ₹27 Cr | ₹24 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹96 Cr | ₹81 Cr | ₹72 Cr | ₹122 Cr | ₹123 Cr |
| Total Current Liabilities | ₹2,895 Cr | ₹2,592 Cr | ₹2,879 Cr | ₹2,990 Cr | ₹3,412 Cr |
| Total Liabilities | ₹6,643 Cr | ₹5,780 Cr | ₹5,572 Cr | ₹6,373 Cr | ₹6,761 Cr |
| ASSETS | |||||
| Gross Block | ₹3,303 Cr | ₹2,897 Cr | ₹2,873 Cr | ₹3,325 Cr | ₹3,232 Cr |
| Less: Accumulated Depreciation | ₹1,203 Cr | ₹1,009 Cr | ₹1,020 Cr | ₹1,026 Cr | ₹898 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹2,100 Cr | ₹1,888 Cr | ₹1,853 Cr | ₹2,298 Cr | ₹2,333 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹161 Cr | ₹100 Cr | ₹80 Cr | ₹48 Cr | ₹56 Cr |
| Non Current Investments | ₹291 Cr | ₹340 Cr | ₹197 Cr | ₹439 Cr | ₹540 Cr |
| Long Term Investment | ₹291 Cr | ₹340 Cr | ₹197 Cr | ₹439 Cr | ₹540 Cr |
| Quoted | ₹271 Cr | ₹323 Cr | ₹1.11 Cr | ₹2.08 Cr | ₹4.78 Cr |
| Unquoted | ₹28 Cr | ₹25 Cr | ₹204 Cr | ₹445 Cr | ₹544 Cr |
| Long Term Loans & Advances | ₹164 Cr | ₹140 Cr | ₹256 Cr | ₹217 Cr | ₹211 Cr |
| Other Non Current Assets | ₹27 Cr | ₹95 Cr | ₹123 Cr | ₹12 Cr | ₹10 Cr |
| Total Non-Current Assets | ₹3,030 Cr | ₹2,681 Cr | ₹2,603 Cr | ₹3,130 Cr | ₹3,399 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | ₹70 Cr | ₹106 Cr | ₹51 Cr | - |
| Quoted | - | ₹70 Cr | ₹106 Cr | ₹51 Cr | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹1,635 Cr | ₹1,278 Cr | ₹1,126 Cr | ₹1,147 Cr | ₹1,174 Cr |
| Raw Materials | ₹676 Cr | ₹416 Cr | ₹507 Cr | ₹522 Cr | ₹575 Cr |
| Work-in Progress | ₹73 Cr | ₹52 Cr | ₹48 Cr | ₹51 Cr | ₹48 Cr |
| Finished Goods | ₹585 Cr | ₹213 Cr | ₹439 Cr | ₹462 Cr | ₹278 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹42 Cr | ₹40 Cr | ₹34 Cr | ₹27 Cr | ₹23 Cr |
| Other Inventory | ₹259 Cr | ₹557 Cr | ₹98 Cr | ₹86 Cr | ₹250 Cr |
| Sundry Debtors | ₹1,289 Cr | ₹1,203 Cr | ₹1,142 Cr | ₹1,299 Cr | ₹1,207 Cr |
| Debtors more than Six months | ₹39 Cr | ₹65 Cr | ₹165 Cr | ₹125 Cr | ₹240 Cr |
| Debtors Others | ₹1,291 Cr | ₹1,179 Cr | ₹1,027 Cr | ₹1,219 Cr | ₹1,010 Cr |
| Cash and Bank | ₹213 Cr | ₹137 Cr | ₹191 Cr | ₹316 Cr | ₹187 Cr |
| Cash in hand | ₹0.46 Cr | ₹0.27 Cr | ₹0.19 Cr | ₹0.27 Cr | ₹0.27 Cr |
| Balances at Bank | ₹196 Cr | ₹121 Cr | ₹163 Cr | ₹261 Cr | ₹175 Cr |
| Other cash and bank balances | ₹17 Cr | ₹15 Cr | ₹28 Cr | ₹55 Cr | ₹12 Cr |
| Other Current Assets | ₹321 Cr | ₹276 Cr | ₹229 Cr | ₹169 Cr | ₹648 Cr |
| Interest accrued on Investments | ₹0.36 Cr | ₹0.24 Cr | ₹0.14 Cr | ₹1.33 Cr | ₹0.12 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | ₹9.81 Cr | ₹0.82 Cr | ₹0.55 Cr |
| Prepaid Expenses | ₹75 Cr | ₹62 Cr | ₹71 Cr | ₹64 Cr | ₹54 Cr |
| Other current_assets | ₹246 Cr | ₹214 Cr | ₹148 Cr | ₹103 Cr | ₹593 Cr |
| Short Term Loans and Advances | ₹155 Cr | ₹136 Cr | ₹175 Cr | ₹153 Cr | ₹145 Cr |
| Advances recoverable in cash or in kind | ₹69 Cr | ₹32 Cr | ₹65 Cr | ₹57 Cr | ₹57 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹86 Cr | ₹103 Cr | ₹110 Cr | ₹97 Cr | ₹88 Cr |
| Total Current Assets | ₹3,613 Cr | ₹3,099 Cr | ₹2,969 Cr | ₹3,135 Cr | ₹3,362 Cr |
| Net Current Assets (Including Current Investments) | ₹717 Cr | ₹507 Cr | ₹90 Cr | ₹145 Cr | ₹-50 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹6,643 Cr | ₹5,780 Cr | ₹5,572 Cr | ₹6,373 Cr | ₹6,761 Cr |
| Contingent Liabilities | ₹119 Cr | ₹98 Cr | ₹475 Cr | ₹632 Cr | ₹834 Cr |
| Total Debt | ₹1,669 Cr | ₹1,796 Cr | ₹2,415 Cr | ₹2,774 Cr | ₹2,792 Cr |
| Book Value | 337.08 | 276.83 | 230.95 | 242.83 | 262.48 |
| Adjusted Book Value | 337.08 | 276.83 | 230.95 | 242.83 | 262.48 |
Compare Balance Sheet of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹8,925.4 Cr | -3.3% | -7.9% | 23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | -3.3% |
-7.9% |
23.6% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses